What drives MRI-measured cortical atrophy in multiple sclerosis?

Multiple Sclerosis

Volumn 21, Issue 10, 2015, Pages 1280-1290

  Popescu, V ^a   Klaver, R ^a   Voorn, P ^a   Galis De Graaf, Y ^a   Knol, D L ^a   Twisk, J W R ^a   Versteeg, A ^a   Schenk, G J ^a   Van Der Valk, P ^a   Barkhof, F ^a   De Vries, H E ^a   Vrenken, H ^a   Geurts, J J G ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

brain atrophy; gray matter; histopathology; MRI; Multiple sclerosis; neurodegeneration

Indexed keywords

MYELIN;

ADULT; AGED; ANTERIOR CINGULATE; ARTICLE; ASTROCYTE; AUTOPSY; BRAIN ATROPHY; BRAIN CORTEX; BRAIN SIZE; BRAIN TISSUE; CELL DENSITY; CELL SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; FEMALE; GRAY MATTER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFERIOR FRONTAL GYRUS; INFERIOR PARIETAL LOBULE; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NERVE CELL; NERVE FIBER; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OLIGODENDROGLIA; PREDICTION; SENSITIVITY AND SPECIFICITY; SUPERIOR FRONTAL GYRUS; SUPERIOR TEMPORAL GYRUS; SYNAPSE; VERY ELDERLY; ATROPHY; DEGENERATIVE DISEASE; IMAGE PROCESSING; PARIETAL LOBE; PATHOLOGY; PROCEDURES;

ADULT; AGED; AGED, 80 AND OVER; ATROPHY; CEREBRAL CORTEX; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEURODEGENERATIVE DISEASES; PARIETAL LOBE;

EID: 84926449661     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458514562440     Document Type: Article

References (33)

1. Giorgio A, Battaglini M, Smith SM,. Brain atrophy assessment in multiple sclerosis: importance and limitations. Neuroimaging Clin N Am 2008; 18: 675-686.
2. Derakhshan M, Caramanos Z, Giacomini PS,. Evaluation of automated techniques for the quantification of grey matter atrophy in patients with multiple sclerosis. Neuroimage 2010; 52: 1261-1267.
3. Geurts JJ, Stys PK, Minagar A,. Gray matter pathology in (chronic) MS: modern views on an early observation. J Neurol Sci 2009; 282: 12-20.
4. Fisher E, Lee JC, Nakamura K,. Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 2008; 64: 255-265.
5. Benedict RH, Ramasamy D, Munschauer F,. Memory impairment in multiple sclerosis: correlation with deep grey matter and mesial temporal atrophy. J Neurol Neurosurg Psychiatry 2009; 80: 201-206.
6. Chard D, Miller D., Grey matter pathology in clinically early multiple sclerosis: evidence from magnetic resonance imaging. J Neurol Sci 2009; 282: 5-11.
7. Dutta R, Chang A, Doud MK,. Demyelination causes synaptic alterations in hippocampi from multiple sclerosis patients. Ann Neurol 2011; 69: 445-454.
8. Magliozzi R, Howell OW, Reeves C,. A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol 2010; 68: 477-493.
9. Papadopoulos D, Dukes S, Patel R,. Substantial archaeocortical atrophy and neuronal loss in multiple sclerosis. Brain Pathol 2009; 19: 238-253.
10. Peterson JW, Bo L, Mork S,. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001; 50: 389-400.
11. Vercellino M, Masera S, Lorenzatti M,. Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter. J Neuropathol Exp Neurol 2009; 68: 489-502.
12. Wegner C, Esiri MM, Chance SA,. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 2006; 67: 960-967.
13. Seewann A, Kooi EJ, Roosendaal SD,. Translating pathology in multiple sclerosis: the combination of postmortem imaging, histopathology and clinical findings. Acta Neurol Scand 2009; 119: 349-355.
14. Battaglini M, Jenkinson M, De Stefano N., Evaluating and reducing the impact of white matter lesions on brain volume measurements. Hum Brain Mapp 2012; 33: 2062-2071.
15. Sanfilipo MP, Benedict RH, Sharma J,. The relationship between whole brain volume and disability in multiple sclerosis: a comparison of normalized gray vs. white matter with misclassification correction. Neuroimage 2005; 26: 1068-1077.
16. Chard DT, Jackson JS, Miller DH,. Reducing the impact of white matter lesions on automated measures of brain gray and white matter volumes. J Magn Reson Imaging 2010; 32: 223-228.
17. Dale AM, Fischl B, Sereno MI,. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 1999; 9: 179-194.
18. Fischl B, Sereno MI, Dale AM., Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage 1999; 9: 195-207.
19. Smith SM, Zhang Y, Jenkinson M,. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002; 17: 479-489.
20. Geurts JJ, Roosendaal SD, Calabrese M,. Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI. Neurology 2011; 76: 418-424.
21. Nordquist RE, Vanderschuren LJ, Jonker AJ,. Expression of amphetamine sensitization is associated with recruitment of a reactive neuronal population in the nucleus accumbens core. Psychopharmacology 2008; 198: 113-126.
22. Abercrombie M., Estimation of nuclear population from microtome sections. Anat Rec 1946; 94: 239-247.
23. Hedreen JC., What was wrong with the Abercrombie and empirical cell counting methods? A review. Anat Rec 1998; 250: 373-380.
24. Aarts E, Verhage M, Veenvliet JV,. A solution to dependency: using multilevel analysis to accommodate nested data. Nat Neurosci 2014; 17: 491-496.
25. Reed JL, Kaas JH., Statistical analysis of large-scale neuronal recording data. Neural Netw 2010; 23: 673-684.
26. Vercellino M, Plano F, Votta B,. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 2005; 64: 1101-1107.
27. Chard DT, Griffin CM, McLean MA,. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain 2002; 125: 2342-2352.
28. Sastre-Garriga J, Ingle GT, Chard DT,. Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis. Arch Neurol 2005; 62: 569-573.
29. Trapp BD, Peterson J, Ransohoff RM,. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278-285.
30. Calabrese M, Atzori M, Bernardi V,. Cortical atrophy is relevant in multiple sclerosis at clinical onset. J Neurol 2007; 254: 1212-1220.
31. Geurts JJ, Pouwels PJ, Uitdehaag BM,. Intracortical lesions in multiple sclerosis: improved detection with 3D double inversion-recovery MR imaging. Radiology 2005; 236: 254-260.
32. Seewann A, Kooi EJ, Roosendaal SD,. Postmortem verification of MS cortical lesion detection with 3D DIR. Neurology 2012; 78: 302-308.
33. Steenwijk MD, Daams M, Pouwels PJ,. What explains gray matter atrophy in long-standing multiple sclerosis? Radiology 2014: 132708.